Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DB9C7F
|
|||
| Drug Name |
BI 1839100
|
|||
| Indication | Pulmonary fibrosis [ICD-11: CB03.4; ICD-10: J84.1] | Phase 1 | [1] | |
| Company |
Boehringer Ingelheim Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05354453) Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BI 1839100 in Healthy Male Subjects (Single-blind, Randomised, Placebo-controlled, Parallel Group Design). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.